Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial

Author： Andersson Lars-Magnus  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.45, Iss.7, 2013-07, pp. : 543-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

By Calza Leonardo   Trapani Filippo   Salvadori Caterina   Magistrelli Eleonora   Manfredi Roberto   Colangeli Vincenzo   Di Bari Maria Assunta   Borderi Marco   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 147-154

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïïve human immunodeficiency virus-1 patients in Sweden

By Thuresson Per-Olof   Heeg Bart   Lescrauwaet Benedicte   Sennfäält Karin   Alaeus Annette   Neubauer Aljoscha  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 4, 2011-04 ,pp. : 304-312

Informa Healthcare

Access to resources Recommend Favorite

Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial

By Cohen C.   Nieto-Cisneros L.   Zala C.   Fessel W. J.   Gonzalez-Garcia J.   Gladysz A.   McGovern R.   Adler E.   McLaren C.    

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1683-1692

Informa Healthcare

Access to resources Recommend Favorite

Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy

By Calza Leonardo   Manfredi Roberto   Trapani Filippo   Salvadori Caterina   Colangeli Vincenzo   Borderi Marco   Grossi Gabriele   Motta Roberto   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 5, 2012-05 ,pp. : 381-387

Informa Healthcare

Access to resources Recommend Favorite

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen

By Yilmaz Aylin   Ståhle Lars   Hagberg Lars   Svennerholm Bo   Fuchs Dietmar   Gisslén Magnus  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 11-12, 2004-12 ,pp. : 823-828

Informa Healthcare

Access to resources Recommend Favorite